Y hace falta un descenso mayor al 20% para lograr objetivos como, por ejemplo, la remisin de diabetes o prediabetes
The scale and BMI miss this
[1] [3] Pharmacologically, the medication's approximately five-day half-life provides some flexibility, but any change to your dosing schedule should follow the FDA guidance of maintaining at least 72 hours between doses
1 Next Steps and Future Implications These early insights from the COURAGE trial are consistent with recently published pre-clinical data in rodents and non-human primates and clearly establish the principle that blocking GDF8 with or without activin A can preserve muscle and further increase fat loss in patients being treated with GLP-1 therapy, thereby improving the quality of weight loss, continued Yancopoulos, in the press release
In its statement announcing the drugs availability, Novo Nordisk said it would closely monitor demand and work with regulators and providers to ensure the drug was accessible to eligible patients